VOGO-0.3 15'S

About

Voglibose 0.3mg is an alpha-glucosidase inhibitor, a class of oral antidiabetic drugs used in the management of type 2 diabetes mellitus. Its primary mechanism of action involves delaying the digestion and absorption of carbohydrates in the small intestine. By inhibiting alpha-glucosidase enzymes, voglibose reduces the breakdown of complex carbohydrates into simpler sugars, thereby slowing down glucose absorption into the bloodstream. This leads to a significant reduction in postprandial (after-meal) blood glucose excursions, which is crucial for achieving better glycemic control and preventing long-term diabetic complications such as cardiovascular events and neuropathy. Voglibose is typically prescribed as an adjunct to diet and exercise, and it can be used alone or in combination with other antidiabetic agents. It is particularly effective in managing post-meal hyperglycemia and improving overall glycemic parameters.

Uses

• Management of type 2 diabetes mellitus.
• Reduction of postprandial hyperglycemia.
• As an adjunct to diet and exercise.
• Prevention of type 2 diabetes in individuals with impaired glucose tolerance.

Directions For Use

Take one tablet (0.3mg) orally three times a day, immediately before each main meal.

Benefits

• Effectively lowers post-meal blood sugar levels.
• Reduces the risk of diabetic complications.
• Can be used in combination with other antidiabetic drugs.
• Helps improve overall glycemic control.
• Minimal risk of hypoglycemia when used alone.
• Supports cardiovascular health by reducing glucose spikes.

Side Effects

• Abdominal pain
• Diarrhea
• Flatulence
• Nausea
• Vomiting
• Indigestion
• Constipation
• Skin rash
• Headache
• Dizziness
• Hypoglycemia (rare, especially when used alone)
• Increased liver enzymes (rare)

Safety Measures

• Alcohol - Alcohol can affect blood sugar levels; use with caution and monitor glucose closely.
• Pregnancy - Not recommended during pregnancy; consult a doctor for alternative treatments.
• Breastfeeding - Not recommended during breastfeeding; consult a doctor for advice.
• Liver - Use with caution in patients with severe liver impairment; regular monitoring of liver function is advised.
• Kidney - Use with caution in patients with severe kidney impairment; dosage adjustment may be necessary.
• Lung - Generally safe for use in patients with lung conditions; no specific precautions are usually needed.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.